Excretion of 3-methoxy-4-hydroxymandelic acid (VMA) in depressed patients treated with antidepressant drugs
- 1 December 1964
- journal article
- research article
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 2 (4), 257-266
- https://doi.org/10.1016/0022-3956(64)90012-3
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- BIOCHEMICAL AND PRESSOR EFFECTS OF ORAL d, l‐DIHYDROXYPHENYLALANINE IN PATIENTS PRETREATED WITH ANTIDEPRESSANT DRUGS *Annals of the New York Academy of Sciences, 1963
- The excretion of 3-methoxy-4-hydroxymandelic acid in normal and in chronic schizophrenic male subjects Effect of reserpine and chlorpromazineJournal of Psychiatric Research, 1962
- Prognostic Factors in Treatment of Depressive States with ImipramineBMJ, 1962
- Clinical and Chemical Studies with α -Methyl-Dopa in Patients with HypertensionCirculation, 1962
- THE METABOLISM OF DIHYDROXYPHENYLALANINE IN MAN BEFORE AND AFTER ADMINISTRATION OF PSYCHOTROPIC DRUGS *Annals of the New York Academy of Sciences, 1962
- A Controlled Trial of Iproniazid in the Treatment of Endogenous DepressionJournal of Mental Science, 1960
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960
- Effect of Marsilid on Excretion of 3-Methoxy-4-Hydroxymandelic Acid in ManScandinavian Journal of Clinical and Laboratory Investigation, 1959
- Iproniazid Treatment and Metabolism of Labeled Epinephrine in SchizophrenicsScience, 1958
- Multiple Range and Multiple F TestsBiometrics, 1955